Superluminal Medicines
Superluminal Medicines develops small-molecule therapeutics using generative biology, chemistry, machine learning, and proprietary data infrastructure. Its Hyperloop platform integrates structure-based drug discovery, computational approaches, and experimental research to identify and validate drug candidates. The company focuses on GPCR-targeted treatments, particularly for cardiometabolic diseas
Series BBoston, MA, USA50 people
5 open roles
Roles are read from Superluminal Medicines’s Greenhouse every hour and disappear here as soon as they close there.